Emvoid 125mg/80mg Capsule
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Aprepitant (125mg) + Aprepitant (80mg)
Overview Emvoid 125mg/80mg Capsule
Navinex 125 mg/80 mg capsules are a prescription medication for managing chemotherapy-induced nausea and vomiting. This medication works by blocking the signals to the brain that trigger these symptoms. Navinex 125 mg/80 mg capsules are administered as directed by your physician, with or without food. Dosage and treatment duration are individualized based on your response and health status. Continue taking this medication as prescribed; premature discontinuation may lead to symptom recurrence and disease progression. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include constipation, dyspepsia, headache, fatigue, anorexia, and hiccups; most are transient. Report any concerning side effects to your doctor immediately. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential additive drowsiness. Consult your doctor before using Navinex if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Emvoid 125mg/80mg Capsule
Chemotherapy-induced emesis
Major Benefits of Emvoid 125mg/80mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Emvoid 125 mg/80 mg Capsules can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Emvoid 125mg/80mg Capsule:
- Constipation
- Indigestion
- Headache
- Tiredness
- Loss of appetite
- Hiccup
- Increased liver enzymes
How to use Emvoid 125mg/80mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Emvoid 125 mg/80 mg Capsules. These capsules can be ingested with or without food, though consistent timing is recommended.
How Emvoid 125mg/80mg Capsule works:
Aprepitant dual-dose (125mg/80mg) capsules, marketed as Emvoid, counteract nausea and vomiting induced by anticancer therapies. This effect is achieved by inhibiting a neurotransmitter in the brain responsible for triggering these side effects.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Emvoid 125 mg/80 mg Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Emvoid 125 mg/80 mg capsules in pregnancy are absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Emvoid 125 mg/80 mg Capsules is likely inadvisable. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Emvoid 125 mg/80 mg capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Emvoid 125 mg/80 mg capsules may be administered to patients with renal impairment without modification of the dosage.
LiverSAFE IF PRESCRIBED
The use of Emvoid 125 mg/80 mg Capsules in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Emvoid 125mg/80mg Capsule :
Should you forget to take your Emvoid 125 mg/80 mg Capsule, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Emvoid 125mg/80mg Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
3,018 People bought this recently